Ensuring timely antibody delivery in the face of supply chain challenges - contact us for solutions

Rat Anti-Mouse CD5-FITC (4H8E5)

Only %1 left
Cat. No.:
1546-02,
1546-02S
FITC Anti-Mouse CD5 antibody for use in flow cytometry assays.
As low as $99.00
Size Price (USD) Quantity
0.5 mg (Cat. No. 1546-02) $275.00
0.1 mg (Cat. No. 1546-02S) $99.00
More Information
Clone 4H8E5
Isotype Rat IgG2aκ
Isotype Control Rat IgG2a-FITC (KLH/G2a-1-1)
Specificity Mouse CD5
Alternative Names Lyt-1, Ly-1, Lymphocyte antigen 1, Ly-12, Ly-A, T1, Tp67
Description CD5, also known as Lyt-1, is a monomeric type I transmembrane glycoprotein expressed on thymocytes, T lymphocytes, and a subset of B lymphocytes, but not on natural killer (NK) cells. It has been identified as the major ligand of the B-cell antigen CD72. The frequency of CD5+ B cells exhibits strain-dependent variation, and the phenotypic, anatomical, functional, developmental, and pathological characteristics of the CD5+ B cells suggest that they may represent a distinct lineage, known as B-1 cells. Binding of CD5 on the T cell surface can augment alloantigen- or mitogen-induced lymphocyte proliferation and induces increased cytosolic free calcium, IL-2 secretion, and IL-2R expression. It has been proposed that CD5 negatively regulates signal transduction mediated by the T-cell and B-cell receptors.
Conjugate FITC (Fluorescein)
Buffer Formulation Phosphate buffered saline containing < 0.1% sodium azide
Clonality Monoclonal
Concentration 0.1 mg/mL, 0.5 mg/mL
Volume 1.0 mL
Recommended Storage 2-8°C; Avoid exposure to light
Applications Flow Cytometry – Quality tested 1

RRID Number AB_2794857
Gene ID 12507 (Mouse)
Gene ID Symbol Cd5 (Mouse)
Gene ID Aliases Ly-1; Ly-12; Ly-A; Lyt-1
UniProt ID P13379 (Mouse)
UniProt Name CD5_MOUSE (Mouse)

Certificate of Analysis Lookup

Enter the Catalog Number and Lot Number for the Certificate of Analysis you wish to view


Need help with this product?
or call 800.722.2255
  1. 1. Koneru M, Schaer D, Monu N, Ayala A, Frey AB. Defective proximal TCR signaling inhibits CD8+ tumor-infiltrating lymphocyte lytic function. J Immunol. 2005;174:1830-40. (FC)